Therapeutic uses of inhibitors of RTP801

Details Therapeutic uses of inhibitors of RTP801 Therapeutic uses of inhibitors of RTP801

2007-01-18

2011-11-29

Vivlemore, Tracy (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C514S04400A

Reexamination Certificate

active

08067570

ABSTRACT:
The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases respiratory conditions and hearing disorders based upon inhibition of the RTP801 gene and/or protein.

REFERENCES:
patent: 5898031 (1999-04-01), Crooke
patent: 6107094 (2000-08-01), Crooke
patent: 6372249 (2002-04-01), Smith et al.
patent: 6455674 (2002-09-01), Einat et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 6555667 (2003-04-01), Einat et al.
patent: 6673549 (2004-01-01), Furness et al.
patent: 6740738 (2004-05-01), Einat et al.
patent: 7056704 (2006-06-01), Tuschl et al.
patent: 7078196 (2006-07-01), Tuschl et al.
patent: 7432249 (2008-10-01), Crooke
patent: 7432250 (2008-10-01), Crooke
patent: 7452987 (2008-11-01), Giese et al.
patent: 7459547 (2008-12-01), Zamore et al.
patent: 7629321 (2009-12-01), Crooke
patent: 2002/0119463 (2002-08-01), Faris
patent: 2002/0137077 (2002-09-01), Hopkins et al.
patent: 2003/0104973 (2003-06-01), Einat
patent: 2003/0108871 (2003-06-01), Kaser
patent: 2003/0165864 (2003-09-01), Lasek et al.
patent: 2003/0207840 (2003-11-01), Riggins et al.
patent: 2005/0080246 (2005-04-01), Allerson
patent: 2006/0069056 (2006-03-01), Feinstein et al.
patent: 2006/0217329 (2006-09-01), Feinstein
patent: 2007/0281326 (2007-12-01), Wechsler
patent: 2008/0064650 (2008-03-01), Feinstein
patent: 2008/0188647 (2008-08-01), Khvorova
patent: 2008/0269156 (2008-10-01), Feinstein et al.
patent: 19816395 (1999-10-01), None
patent: 1 394 274 (2004-03-01), None
patent: 1009753 (2005-04-01), None
patent: 2003-259877 (2003-09-01), None
patent: WO 99/09046 (1999-02-01), None
patent: WO 00/14283 (2000-03-01), None
patent: WO 00/44895 (2000-08-01), None
patent: WO 00/44914 (2000-08-01), None
patent: WO 00/61620 (2000-10-01), None
patent: WO 00/77022 (2000-12-01), None
patent: WO 01/12659 (2001-02-01), None
patent: WO 01/36646 (2001-05-01), None
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 01/77289 (2001-10-01), None
patent: WO 02/31111 (2002-04-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO 02/46465 (2002-06-01), None
patent: WO 02/055693 (2002-07-01), None
patent: WO 02/059300 (2002-08-01), None
patent: WO 02/059300 (2002-08-01), None
patent: WO 02/101075 (2002-12-01), None
patent: WO 03/010205 (2003-02-01), None
patent: WO 03/064621 (2003-08-01), None
patent: WO 03/064621 (2003-08-01), None
patent: WO 03/070918 (2003-08-01), None
patent: WO 03/074654 (2003-09-01), None
patent: WO 03/101283 (2003-12-01), None
patent: WO 2004/015107 (2004-02-01), None
patent: WO 2004/015107 (2004-02-01), None
patent: WO 2004/018999 (2004-03-01), None
patent: WO 2004/030615 (2004-04-01), None
patent: WO 2004/035615 (2004-04-01), None
patent: WO 2004/035615 (2004-04-01), None
patent: WO 2004/039956 (2004-05-01), None
patent: WO 2004/045543 (2004-06-01), None
patent: WO 2004/045545 (2004-06-01), None
patent: WO 2004/060270 (2004-07-01), None
patent: WO 2004/076633 (2004-09-01), None
patent: WO 2004/091383 (2004-10-01), None
patent: WO 2004/111191 (2004-12-01), None
patent: WO 2004/111191 (2004-12-01), None
patent: WO 2005/016000 (2005-02-01), None
patent: WO 2005/062937 (2005-07-01), None
patent: WO 2005/062937 (2005-07-01), None
patent: WO 03/062394 (2007-07-01), None
patent: WO 03/062394 (2007-07-01), None
patent: WO 2007/084684 (2007-07-01), None
patent: WO 2007/087451 (2007-08-01), None
patent: WO 2007/087451 (2007-08-01), None
International Search Report issued by the International Searching Authority (ISA/US) on Jan. 24, 2008 in connection with International Application No. PCT/US07/01468.
Written Opinion of the International Searching Authority (ISA/US) issued on Jan. 24, 2008 in connection with International Application No. PCT/US07/01468.
Shoshani, T., et al., (2002) Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene RTP801, Involved in Apoptosis. Mol. Cell. Biol., 22(7): 2283-2293.
Nuttal, A., (1999) Sound-Induced Cochlear Ischemia/Hypoxia as a Mechanism of Hearing Loss (Review). Noise & Health, 5: 17-31.
Bliss, M. and Simini, B., (1999) When Are the Seeds of Postoperative Pressure Sores Sown? BMJ, 319: 863-864.
Arden, G.B., et al., (2005) Spare the Rod and Spoil the Eye? Br. J. Ophthalmol., 89: 764-769.
Biju, M.P., et al., (2005) Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent.Am. J. Physiol. Renal Physiol., 289: F1217-F1226.
Czauderna, F., et al., (2003) Structural Variations and Stabilising Modifications of Synthetic siRNAs in Mammalian Cells.Nucleic Acids Res., 31(11): 2705-2716.
Amarzguioui M, Holen T, Babaie E, Prydz H. (2003) Tolerance for mutations and chemical modifications in a siRNA.Nucleic Acids Res. 31(2):589-95.
Barik, Sailen (2005). “Silence of the Transcripts; RNA Interference in Medicine,”J. Mol. Med. 83:764-773.
Bartel, David P. et al. (2004). “MicroRNAs: Genomics Biogenesis, Mechanism, and Function,”Cell, 116:281-297.
Bernstein, Emily et al. (2001). “Role for a Bidentate Ribonuclease in the Initiation Step of RNA Interference,”Nature, 409:363-366.
Bitko, Vira et al. (2004). “Inhibition of Respiratory Viruses by Nasally Administered siRNA,”Nature Medicine, 11(1):50-55.
Brafman, A. et al., (2004) “Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient Mice,”Investigative Ophthalmology&Visual Science, 45(10): 3796-3805.
Braasch DA, et al. (2003) “RNA interference in mammalian cells by chemically-modified RNA,”Biochemistry, 42:7967-7975.
Brugarolas, J. et al., (2004) “Regulation of mTOR Function in Response to Hypoxia by REDD1 and the TSC1/TSC2 Tumor Suppressor Complex,”Genes&Development, 18: 2893-2904.
Brummelkamp, Thijn R. et al. (2002). “A System for Stable Expression of Short Interfering RNAs in Mammalian Cells,”Science, 296: 550-553.
Caplen, Natasha J. et al. (2001). “Specific Inhibition of Gene Expression by Small Double-Stranded RNAs in Invertebrate Vertebrate Systems,”PNAS, 98(17):9742-9747.
Chakraborty, Chiranjib (2007) “Potentiality of Small Interfering RNAs (siRNA) as Recent Therapeutic Targets for Gene-Silencing,”Current Drug Targets, 8:469-482.
Chalk, Alistair M. et al., (2004). “Improved and Automated Prediction of Effective siRNA,”Biochemical and Biophysical Research Communications, 319:264-274.
Elbashir, Sayda M. et al. (2000). “RNA Interference is Mediated by 21- and 22-nucleotide RNAs,”Genes&Development, 15:188-200.
Elbashir, Sayda M. et al. (2001). “Duplexes of 21-nucleotide RNAs mediated RNA interference in cultured mammalian cells,”Nature, 411:494-498.
Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. (2001) “Functional anatomy of siRNAs for mediating efficient RNAi inDrosophila melanogasterembryo lysate,”EMBO J. 20(23):6877-88.
Fire, Andrew et al., (1998). “Potent and Specific Genetic Interference by Double-stranded RNA inCaenorhabditis elegans,” Nature, 391:806-811.
Ellisen, L. et al., (2002) “REDD1, A Developmentally Regulated Transcriptional Target of p63 and p53, Links p63 to Regulation of Reactive Oxygen Species,”Molecular Cell, 10: 995-1005.
Frolov, A. et al., (2003) “Response Markers and the Molecular Mechanisms of Action of Gleevec in Gastrointestinal Stromal Tumors,”Molecular Cancer Therapeutics, 2: 699-709.
Kim, J. et al., (2003) “Identification of Amyloid β-peptide Responsive Genes by cDNA Microarray Technology: Involvement ofRTP801in Amyloid β-peptide Toxicity,”Experimental and Molecular Medicine, 35(5): 403-411.
Lal, A. et al., (2001) “Transcriptional Response to Hypoxia in Human Tumors,”Journal of the National Cancer Institute, 93(17): 1337-1343.
Lee, Youngtae et al., (2003). “The nuclear RNase III Drosha initiates microRNA processing,” Nature, 4

Affiliated with

Also associated with

Rating

Therapeutic uses of inhibitors of RTP801 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of inhibitors of RTP801, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of inhibitors of RTP801 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4264373